Urology billing services handle the claims, coding and follow-up for a practice whose revenue runs through cystourethroscopy, stone procedures, prostate biopsy and BPH treatment, urodynamic testing, and continence device implantation — a mix in which nearly every procedure sits inside a bundling edit, a global period, or both. Urology is unusually exposed to bundling edits because so much of the work is endoscopic, and endoscopic procedures absorb related services that cannot be billed separately. In 2026 the prostate biopsy code family was also rebuilt from the ground up. If you want the code-level reference before the strategy, our companion piece on urology medical billing codes and denial tips lists the edits line by line.
The five service lines that carry a urology practice
Most urology groups build revenue on five service lines, each with its own coding personality:
- Endoscopy: diagnostic cystourethroscopy, cystoscopy with biopsy, and transurethral resection of bladder tumors.
- Stone disease: ureteroscopy with stone removal or lithotripsy, ureteral stent placement, and extracorporeal shock wave lithotripsy.
- Prostate: prostate biopsy, transurethral resection of the prostate, and minimally invasive BPH therapies.
- Functional urology: urodynamic testing, intravesical chemodenervation, sacral neuromodulation, and continence device implantation.
- Ancillaries: post-void residual measurement, transrectal ultrasound, and in-office laboratory work.
The ancillary and functional lines are high-frequency and low-dollar, so errors compound quietly. The stone and prostate lines are higher-dollar, so one sequencing error is immediately expensive.
Endoscopic bundling is where urology loses the most money
Trap one: the “separate procedure” designation. Diagnostic cystourethroscopy, CPT 52000, carries it. In Medicare’s National Correct Coding Initiative practitioner edit file, CPT 52000 is bundled into CPT 52351, CPT 52353, CPT 52601, CPT 52441, CPT 52287, and CPT 52332 at a modifier indicator of 0 — no modifier will unbundle it. The scope used to reach the target is not separately billable.
Trap two: treating an endoscopic procedure as a sum of parts. The CMS NCCI Policy Manual (Chapter VII, revision date 1/1/2026) states that endoscopic procedures include all minor related functions performed at the same encounter, and gives transurethral resection of the prostate as its example: it includes meatotomy, urethral calibration or dilation, urethroscopy, and cystoscopy. Urinary bladder catheterization performed at the time of, or just before, a more extensive procedure — CPT 51701, CPT 51702, CPT 51703 — is likewise not separately reportable, nor is fluoroscopy.
Trap three: units of service on stone cases. The unit of service for destruction or removal of a renal system calculus is one, not one per stone. CPT 52353 takes a single unit per ureter regardless of how many calculi were treated, and a bilateral procedure takes modifier 50 and one unit rather than two lines. Billing per stone generates denials and overpayment exposure.
Trap four: urodynamics hierarchy errors. Complex cystometrogram codes are hierarchical: CPT 51728 is bundled with CPT 51726 at a modifier indicator of 0, because the more comprehensive study contains the simpler one. Several urodynamic codes also carry a professional/technical split, so equipment ownership and interpretation responsibility decide whether modifier 26 or TC belongs on the claim.
Urology codes payers scrutinize, and why claims come back
| Code | Service | Why it gets denied |
|---|---|---|
| 52000 | Diagnostic cystourethroscopy (separate procedure) | Reported alongside a therapeutic cystoscopic or transurethral procedure |
| 52204 | Cystourethroscopy with biopsy | Multiple units billed; NCCI treats all biopsies during the procedure as one unit |
| 52234, 52235, 52240 | Cystourethroscopy with fulguration or resection of bladder tumor, by lesion size | Size not documented, or a smaller-tumor code added to the larger one for the same lesion |
| 52332, 52005 | Cystourethroscopy with insertion of an indwelling ureteral stent, and with ureteral catheterization | 52332 used for a temporary stent placed and removed at the same procedure; both reported for one ureter |
| 52351, 52352, 52353, 52356 | Ureteroscopy or pyeloscopy: diagnostic, with stone removal, with lithotripsy, and with lithotripsy plus stent | Diagnostic code billed with the therapeutic one; 52353 plus 52332 billed instead of 52356 |
| 50590 | Extracorporeal shock wave lithotripsy | Multiple units for multiple stones; 90-day global period ignored |
| 55705, 55706, 55707, 55708, 55709, 55710, 55711, 55712, 55713, 55714, 55715 | The 2026 prostate biopsy family: 55705 nonimaging-guided (descriptor revised for 2026) and 55706 saturation sampling with image guidance, plus the new approach- and guidance-specific codes 55707, 55708, 55709, 55710, 55711, 55712, 55713, and 55714, and add-on code 55715 | Deleted code 55700 still sitting on the superbill; imaging guidance billed separately when it is already bundled; add-on 55715 omitted on multi-lesion targeted biopsies |
| 52601 | Transurethral resection of the prostate | Cystoscopy, urethroscopy, or dilation unbundled; 90-day global visits billed separately |
| 53854 | Transurethral destruction of prostate tissue by radiofrequency-generated water vapor | 52000 reported with it; BPH severity not documented |
| 52441, 52442 | Transprostatic implant, first and each additional | 52442 billed as a standalone rather than as an add-on to 52441 |
| 51798 | Post-void residual by ultrasound, without imaging | No separate order or documented result; technical-component-only code |
| 51726, 51727, 51728, 51729 | Complex cystometrogram and its urethral and voiding pressure combinations | Lower-level and higher-level studies reported together for one session |
| 52287, 51720 | Bladder chemodenervation by cystoscopy, and instillation of an anticarcinogenic agent | Drug units inconsistent with the administration line; 52000 billed alongside |
Laterality, staged procedures and misused modifiers
Modifier 50. CMS bilateral surgery indicators drive this, and urology has several codes where bilateral work is genuinely possible — CPT 50590, CPT 52332, CPT 52352, CPT 52353, CPT 52356, and CPT 64561 among them. Practitioners report a bilateral surgical procedure with modifier 50 and one unit of service on a single claim line unless the descriptor is already bilateral. Ambulatory surgical centers report differently, using two lines with LT and RT.
Modifier 59 and the X modifiers. These work only where the edit permits. CPT 52234 and CPT 52235 are each bundled with CPT 52204 at a modifier indicator of 1, so a documented distinct service can be separated. CPT 52000 bundled into a therapeutic cystoscopy is a 0-indicator edit, and no modifier helps.
Modifiers 58, 78, and 79. CPT 52601, CPT 52597, CPT 53854, CPT 50590, CPT 53445, and CPT 64581 all carry a 90-day global period in the CY 2026 fee schedule. Staged procedures, returns to the operating room for a related complication, and unrelated procedures in that window each need the right modifier; the wrong one produces both denials and inappropriate write-offs.
What the WISeR model changes about prior authorization
Urology is directly affected by Medicare’s newest prior authorization test. The CMS Innovation Center’s WISeR Model — Wasteful and Inappropriate Service Reduction — runs from January 1, 2026 through December 31, 2031 in six states: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington (CMS WISeR Model). Providers either submit a prior authorization request or accept pre-payment review.
Three of the model’s selected service categories are urologic. Per the CMS WISeR Provider and Supplier Operational Guide:
- Incontinence control devices (national coverage determination 230.10), covering CPT 53440, CPT 53445, CPT 53451, CPT 53452, and CPT 57288.
- Sacral nerve stimulation for urinary incontinence (NCD 230.18), covering CPT 64581, and CPT 64561 when billed with CPT 64590, the generator code CMS uses to distinguish a permanent implant from a trial.
- Diagnosis and treatment of impotence (NCD 230.4), covering penile prosthesis insertion under CPT 54400, CPT 54401, and CPT 54405.
The documentation CMS expects is specific and clinical: for a continence device, evidence of the stress incontinence diagnosis including a cough or bladder stress test, plus conservative measures tried and failed. For sacral neuromodulation, a successful test stimulation showing at least 50% improvement measured through voiding diaries. A partner who cannot assemble that packet before the procedure is scheduled costs you the case.
Separately, the CMS Interoperability and Prior Authorization final rule (CMS-0057-F) sets decision deadlines for impacted payers, which exclude qualified health plan issuers on the federally facilitated exchanges. Expedited requests must be answered inside 72 hours and standard requests inside seven calendar days. From 2026 a denial must carry a specific reason, and to publicly report prior authorization metrics, the first set due by March 31, 2026 (CMS fact sheet, CMS-0057-F). A named denial reason is the raw material for an appeal, which is why a disciplined denial management and appeal workflow returns more than it used to.
The 2026 prostate code rebuild, and what it breaks
Prostate biopsy was rebuilt. CPT 55700 was deleted, and CPT 55705 revised to describe biopsy of the prostate by any approach without imaging guidance. A new family now distinguishes approach and guidance: CPT 55707, CPT 55708, CPT 55709, CPT 55710, CPT 55711, CPT 55712, CPT 55713, CPT 55714, and add-on CPT 55715. Each appears with an active status in the CY 2026 Medicare Physician Fee Schedule relative value file; CPT 55700 does not.
Two new prostate treatment codes also arrived: CPT 52443, cystourethroscopy with initial transurethral anterior prostate commissurotomy using a nondrug-coated balloon catheter followed by therapeutic drug delivery from a drug-coated balloon catheter, including transrectal ultrasound and fluoroscopy when performed, and CPT 52597, transurethral robotic-assisted waterjet resection of the prostate.
A superbill built in 2025 will now generate invalid-code denials on prostate biopsies. Documentation templates need to change too: the new codes turn approach and guidance method into billing-relevant facts the operative note must state plainly.
How to judge a urology billing partner
- Endoscopic bundling fluency. Ask how they handle CPT 52000 when a therapeutic procedure follows. If the answer is “we append modifier 59,” keep looking.
- Stone case discipline. Units of service, bilateral reporting, and the choice between separate codes and the combined lithotripsy-plus-stent code should be second nature.
- 2026 prostate biopsy readiness. They should already have the new code family loaded and know what your operative notes need to say.
- Prior authorization capability under WISeR. If you practice in a model state and implant continence devices, sacral neuromodulators, or penile prostheses, ask how they build and track those submissions.
- Reporting you can act on. Ask what arrives each month without you chasing it. At minimum you want first-pass clean claim performance, the ageing profile of outstanding receivables, and the rest of the monthly billing scorecard. For a formal comparison, see our guide to how to evaluate a medical billing company.
If the search is already underway, our walkthrough on finding the best urology billing company covers the questions to ask and the references worth checking. Procedure-heavy specialties share this problem: component splitting and NCCI edits decide the margin in cardiology billing services for much the same reasons they do in urology.
Urology billing questions we hear most
Can we bill CPT 52000 with a therapeutic cystoscopic procedure?
Generally no. CPT 52000 carries the “separate procedure” designation, and Medicare’s NCCI edits bundle it into therapeutic cystoscopic and transurethral procedures with a modifier indicator of 0, meaning no modifier overrides the edit.
How many units do we report for a ureteroscopic lithotripsy with several stones?
One unit per ureter, regardless of the number of calculi. The CMS NCCI Policy Manual states that the unit of service for destruction or removal of a renal system calculus is one, and that a bilateral procedure takes modifier 50 and a single unit.
What replaced CPT 55700 for prostate biopsy in 2026?
CPT 55700 was deleted. CPT 55705 was revised to describe prostate biopsy by any approach without imaging guidance, and a new family of codes now distinguishes transrectal from transperineal approach, and ultrasound guidance from MRI-ultrasound fusion or in-bore CT or MRI guidance.
Does sacral neuromodulation require prior authorization under Medicare?
In the six WISeR Model states, permanent implantation falls under the model: the provider either submits a prior authorization request or accepts pre-payment review. That applies to Original Medicare; Medicare Advantage plans set their own rules. CMS uses generator code CPT 64590 to distinguish a permanent implant from a trial, and electrode code CPT 64561 is subject to review when billed with it. CMS also expects documentation of a successful test stimulation showing at least 50% improvement measured through voiding diaries.
Verify current CPT, ICD-10, and payer requirements before billing.
Working with AMS Solutions
Urology practices have relied on AMS Solutions for outsourced billing and revenue cycle management since 1992. The firm is physician-founded and based in Dallas, working with practices across the country. Coding is handled by AAPC-certified coders, all U.S.-based, under HIPAA-compliant processes. The relationship is meant to last, not to be re-tendered every year. If your urology claims are catching on endoscopic bundling, the new prostate biopsy codes, or prior authorization for implants, reach out through our contact form. You can also call 866-973-2221.
